AU2003206433A1 - A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males - Google Patents

A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males

Info

Publication number
AU2003206433A1
AU2003206433A1 AU2003206433A AU2003206433A AU2003206433A1 AU 2003206433 A1 AU2003206433 A1 AU 2003206433A1 AU 2003206433 A AU2003206433 A AU 2003206433A AU 2003206433 A AU2003206433 A AU 2003206433A AU 2003206433 A1 AU2003206433 A1 AU 2003206433A1
Authority
AU
Australia
Prior art keywords
progestogen
androgen
males
composition containing
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003206433A
Inventor
Herman Jan Tijmen Coelingh Bennink
Rene Frank Van Der Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Publication of AU2003206433A1 publication Critical patent/AU2003206433A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003206433A 2002-02-15 2003-02-14 A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males Abandoned AU2003206433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075613 2002-02-15
EP02075613.6 2002-02-15
PCT/NL2003/000110 WO2003068315A1 (en) 2002-02-15 2003-02-14 A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males

Publications (1)

Publication Number Publication Date
AU2003206433A1 true AU2003206433A1 (en) 2003-09-04

Family

ID=27675720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003206433A Abandoned AU2003206433A1 (en) 2002-02-15 2003-02-14 A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males

Country Status (2)

Country Link
AU (1) AU2003206433A1 (en)
WO (1) WO2003068315A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).
US20120114757A1 (en) * 2009-02-18 2012-05-10 Bayer Pharma Aktiengesellschaft Particles comprising drospirenone encapsulated in a polymer
EP2398461A1 (en) * 2009-02-18 2011-12-28 Bayer Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
WO2011048613A2 (en) * 2009-10-12 2011-04-28 Lyka Labs Limited Emergency contraceptive
RU2616252C2 (en) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Method of controlling sexual behaviour of male mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364236A (en) * 1962-12-14 1968-01-16 Merck & Co Inc 3-keto-delta4-unsaturated-6-formyl steroids and process for the production thereof
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration

Also Published As

Publication number Publication date
WO2003068315A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
SI1385494T1 (en) Compositions containing formoterol and a steroid for delivery into the lungs
AU2003233609A1 (en) Dose indicators and dispensing canister-indicator assemblies
AU3403201A (en) Drug delivery device and method
AU2003266133A1 (en) Materials and methods for drug delivery and uptake
AU2003205850A1 (en) Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
AU2001232049A1 (en) Improvements in and relating to controlling drug delivery apparatus
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
AU2003262777A1 (en) A method of applying an oral composition and oral composition for use in this method
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
AU2003287726A1 (en) Intraocular delivery compositions and methods
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2003213957A1 (en) Pharmaceutical composition comprising an aromatase inhibitor and an estrogen suitable for hormone replacement therapy for a male
AU2003241313A1 (en) Compositions and methods for stem cell delivery
AU2003247834A1 (en) Therapeutic agent delivery device and method
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
AU2002210687A1 (en) Use of compound in the manufacture of a pharmaceutical for inhibiting steroid sulphatase and steroid dehydrogenase activity
HK1050472B (en) Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof
AU2003206433A1 (en) A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males
AU2003272903A1 (en) Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
AU2003232874A1 (en) A pharmaceutical composition comprising a corticosteroid and a nonsterodial anti-inflammatory agent
AU3926000A (en) Methods and compositions for drug delivery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase